BACKGROUND: @entity8817 ( @entity8817 ) is the most common form of the idiopathic @entity5442 in @entity1 . A subset of @entity1 have the rash of @entity8817 without significant weakness, and the optimal treatments for these @entity1 are unknown. The goal of this study was to describe the development of consensus clinical treatment plans (CTPs) for @entity1 with @entity8817 who have active @entity1910 , without significant muscle involvement, referred to as skin predominant @entity8817 in this manuscript. METHODS: The @entity1 's @entity625 and Rheumatology Research Alliance (CARRA) is a North American consortium of pediatric rheumatology health care providers. CARRA members collaborated to determine consensus on typical treatments for @entity8817 @entity1 with skin findings without significant weakness, to develop CTPs for this subgroup of @entity1 . We used a combination of Delphi surveys and nominal group consensus meetings to develop these CTPs. RESULTS: Consensus was reached on @entity1 characteristics and outcome assessment, and CTPs were developed and finalized for @entity1 with skin predominant @entity8817 . Treatment option A included @entity6383 alone, Treatment option B included @entity6383 and @entity1499 , and Treatment option C included @entity6383 , @entity1499 and @entity288 . CONCLUSIONS: Three CTPs were developed for use in @entity1 with skin predominant @entity8817 , which reflect typical treatment approaches. These are not considered to be specific recommendations or standard of care. Using the CARRA network and prospective data collection, we will be able to apply statistical methods in the future to allow comparisons of @entity8817 @entity1 following these consensus treatment plans.

@entity625 and Rheumatology Research Alliance consensus clinical treatment plans for XXXX with skin predominant disease.

@entity1 :: ('9606', 'Species') :: ['children', 'patients', 'Children', 'patient'] @entity5442 :: ('MESH:D009220', 'Disease') :: ['inflammatory myopathies'] @entity1910 :: ('MESH:D005076', 'Disease') :: ['skin rashes'] @entity625 :: ('MESH:D001168', 'Disease') :: ['Arthritis'] @entity6383 :: ('MESH:D006886', 'Chemical') :: ['hydroxychloroquine'] @entity8817 :: ('MESH:C538250', 'Disease') :: ['JDM', 'Juvenile dermatomyositis'] @entity1499 :: ('MESH:D008727', 'Chemical') :: ['methotrexate'] @entity288 :: ('MESH:D000305', 'Chemical') :: ['corticosteroids']
@entity8817 :: (MESH:C538250,Disease) :: ['juvenile dermatomyositis']
